Research and Markets has announced the addition of the "Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the Niemann Pick C1 Like Protein 1 (NPC1L1) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report provides an overview of key players involved in Niemann Pick C1 Like Protein 1 (NPC1L1) targeted therapeutics development and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Niemann Pick C1 Like Protein 1 Overview
  3. Therapeutics Development
  4. Pipeline Products for Niemann Pick C1 Like Protein 1 - Overview
  5. Pipeline Products for Niemann Pick C1 Like Protein 1 - Comparative Analysis
  6. Niemann Pick C1 Like Protein 1 - Therapeutics under Development by Companies
  7. Niemann Pick C1 Like Protein 1 - Therapeutics under Investigation by Universities/Institutes
  8. Niemann Pick C1 Like Protein 1 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Niemann Pick C1 Like Protein 1 - Products under Development by Companies
  13. Niemann Pick C1 Like Protein 1 - Products under Investigation by Universities/Institutes
  14. Niemann Pick C1 Like Protein 1 - Companies Involved in Therapeutics Development

- Alvogen Korea Co Ltd

- Chong Kun Dang Pharmaceutical Corp

- Esperion Therapeutics Inc

- Kotobuki Pharmaceutical Co Ltd

- Merck & Co Inc

- Zhejiang Hisun Pharmaceutical Co Ltd

For more information about this report visit http://www.researchandmarkets.com/research/b23qzp/niemann_pick_c1